BIOTECH (97) Tome Biosciences: Programmable Genomic Integration (PGI) Platform February 29, 2024February 29, 2024
BIOTECH (96) – Janux Therapeutics: Tumor Activated Masked T-Cell Engager (TRACTr) Platform February 29, 2024
BIOTECH (95) – Ikena Oncology – Rebranding and Restructuring from Discovery to Clinical Focus February 23, 2024February 23, 2024
BIOTECH (94) – Inventiva Pharma: Lanifibranor, a pan-PPAR agonist MASH 치료제 NATIV Phase 3 February 22, 2024February 22, 2024
BIOTECH (93) – RAPT Therapeutics: Zelnecirnon (RPT193, CCR4 Inhibitor) got Clinical Hold February 20, 2024February 20, 2024
BIOTECH (92) – Vertex Non-Opioid Replacement NaV1.8 Inhibitor Suzetrigine (VX-548) Phase 3 February 20, 2024February 20, 2024
BIOTECH (91) – Replicate Bioscience: Self-Replicating mRNA against Therapy-Acquired Neoantigen February 19, 2024